The Board of Directors of PharmaCyte Biotech, Inc. has authorized a buyback plan on January 31, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | 0.00% | -0.47% | -1.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.85% | 17.92M | |
+33.11% | 664B | |
+29.29% | 567B | |
-7.15% | 354B | |
+19.35% | 330B | |
+4.88% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.73% | 148B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. authorizes a Buyback Plan.